Spire B - Search Results

1

Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.

Durand-Zaleski I, Mutuon P, Charreau I, Tremblay C, Rojas D, Pialoux G, Chidiac C, Capitant C, Spire B, Cotte L, Chas J, Meyer L, Molina JM; ANRS IPERGAY Study Group. Durand-Zaleski I, et al. Among authors: spire b. AIDS. 2018 Jan 2;32(1):95-102. doi: 10.1097/QAD.0000000000001658. AIDS. 2018. PMID: 29210777

2

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.

Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Moatti JP, et al. Among authors: spire b. AIDS. 2000 Jan 28;14(2):151-5. doi: 10.1097/00002030-200001280-00010. AIDS. 2000. PMID: 10708285 Clinical Trial.

3

'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.

Duran S, Solas C, Spire B, Carrieri MP, Fuzibet JG, Costagliola D, Lacarelle B, Moatti JP; Cohort Manif 2000 Study Group. Duran S, et al. Among authors: spire b. AIDS. 2001 May 25;15(8):1075-7. doi: 10.1097/00002030-200105250-00024. AIDS. 2001. PMID: 11399998 Clinical Trial. No abstract available.

4

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy.

Duran S, Savès M, Spire B, Cailleton V, Sobel A, Carrieri P, Salmon D, Moatti JP, Leport C; APROCO Study Group. Duran S, et al. Among authors: spire b. AIDS. 2001 Dec 7;15(18):2441-4. doi: 10.1097/00002030-200112070-00012. AIDS. 2001. PMID: 11740195 Clinical Trial.

5

The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.

Duran S, Peytavin G, Carrieri P, Raffi F, Ecobichon JL, Pereira E, Cassuto GP, Spire B, Leport C; Antiprotease Cohort (APROCO) study group. Duran S, et al. Among authors: spire b. AIDS. 2003 May 2;17(7):1096-9. doi: 10.1097/00002030-200305020-00025. AIDS. 2003. PMID: 12700466

6

Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south.

Moatti JP, Spire B, Kazatchkine M. Moatti JP, et al. Among authors: spire b. AIDS. 2004 Jun;18 Suppl 3:S55-61. doi: 10.1097/00002030-200406003-00011. AIDS. 2004. PMID: 15322486

7

Concealment of HIV and unsafe sex with steady partner is extremely infrequent.

Spire B, Bouhnik AD, Obadia Y, Lert F; VESPA study group (ANRS-EN12-VESPA). Spire B, et al. AIDS. 2005 Sep 2;19(13):1431-3. doi: 10.1097/01.aids.0000180789.00251.03. AIDS. 2005. PMID: 16103778 No abstract available.

8

Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B; VESPA Study Group. Préau M, et al. Among authors: spire b. AIDS. 2007 Jan;21 Suppl 1:S19-27. doi: 10.1097/01.aids.0000255081.24105.d7. AIDS. 2007. PMID: 17159583

9

Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study.

Dray-Spira R, Spire B, Heard I, Lert F; VESPA Study Group. Dray-Spira R, et al. Among authors: spire b. AIDS. 2007 Jan;21 Suppl 1:S5-12. doi: 10.1097/01.aids.0000255079.39352.9b. AIDS. 2007. PMID: 17159588 Free article.

10

Awareness of non-occupational HIV postexposure prophylaxis among French people living with HIV: the need for better targeting.

Rey D, Bouhnik AD, Peretti-Watel P, Obadia Y, Spire B; VESPA Study Group. Rey D, et al. Among authors: spire b. AIDS. 2007 Jan;21 Suppl 1:S71-6. doi: 10.1097/01.aids.0000255088.44297.26. AIDS. 2007. PMID: 17159591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters